Author

Crystal Placencia

Observed name: Placencia, Crystal

Institution: Center for Neurosciences

Observed institutions: University of Arizona, Center for Neurosciences, University of Arizona Cancer Center

OpenAlex ID: A5006684635

DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients

2019 · Lukas Vrba, Marc M. Oshiro, et al. · Epigenetics · 44

A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric Recommendations

2019 · Hani M Babiker, Lisa Davis, et al. · Expert Opinion on Investigational Drugs · 5

CTNI-78. A phase 2 double-blind, randomized, prospective, placebo-controlled study of NanO₂TM combined with radiation and temozolomide in patients with newly diagnosed glioblastoma: RESTORE

2025 · Michael Badruddoja, Crystal Placencia, et al. · Neuro-Oncology

Ctni-30. a Phase 2 Double-blind, Randomized, Prospective, Placebo Controlled Study of Nano₂tm Combined With Radiation and Temozolomide in Patients With Newly-diagnosed Glioblastoma: Restore

2024 · Michael A Badruddoja, Crystal Placencia, et al. · Neuro-Oncology

Rare tumor with matched germline whole exome sequencing to identify somatic and inherited variants of clinical significance.

2019 · Bryce Perkins, Ryan Sprissler, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 49

H-index: 2

I10-index: 1